Skip to main content
SpringerLink
Log in

FDA vetoes labelling proposals for finasteride, dutasteride

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Medscape.FDA Advisors Nix Proscar, Avodart Prevention Claims. Media Release: 2 Dec 2010. Available from: URL: http://www.medscape.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

FDA vetoes labelling proposals for finasteride, dutasteride. React. Wkly. 1331, 6 (2010). https://doi.org/10.2165/00128415-201013310-00016

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013310-00016

Keywords

Search

Navigation